Choroideremia presenting as vision loss secondary to choroidal neovascularization

References

• Furgoch MJ, Mewes-Ares J, Radziwon A, Macdonald IM. Molecular genetic diagnostic techniques in choroideremia. Mol Vis. 2014;20:535–44.
   PubMed Web of Science ®Google Scholar
• Kalatzis V, Hamel CP, MacDonald IM. First international choroideremia research symposium. choroideremia: towards a therapy. Am J Ophthalmol. 2013;156(3):433–7 e433. doi:10.1016/j.ajo.2013.05.009.
   PubMedGoogle Scholar
• Dimopoulos IS, Chan S, MacLaren RE, MacDonald IM. Pathogenic mechanisms and the prospect of gene therapy for choroideremia. Expert Opin Orphan Drugs. 2015;3(7):787–98. doi:10.1517/21678707.2015.1046434.
   PubMed Web of Science ®Google Scholar
• Aleman TS, Han G, Serrano LW, Fuerst NM, Charlson ES, Pearson DJ, Chung DC, Traband A, Pan W, Ying GS, et al. Natural history of the central structural abnormalities in choroideremia: A prospective cross-sectional study. Ophthalmology. 2017;124(3):359–73. doi:10.1016/j.ophtha.2016.10.022.
   PubMed Web of Science ®Google Scholar
• Patel RC, Gao SS, Zhang M, Alabduljalil T, Al-Qahtani A, Weleber RG, Yang P, Jia Y, Huang D, Pennesi ME. Optical coherence tomography angiography of choroidal neovascularization in four inherited retinal dystrophies. Retina. 2016;36(12):2339–47. doi:10.1097/IAE.0000000000001159.
   PubMed Web of Science ®Google Scholar
• Ranjan R, Verghese S, Salian R, Manayath GJ, Saravanan VR, Narendran V. OCT angiography for the diagnosis and management of choroidal neovascularization secondary to choroideremia. Am J Ophthalmol Case Rep. 2021;22:101042. doi:10.1016/j.ajoc.2021.101042.
   PubMedGoogle Scholar
• Sanchez-Alcudia R, Garcia-Hoyos M, Lopez-Martinez MA, Sanchez-Bolivar N, Zurita O, Gimenez A, Villaverde C, Rodrigues-Jacy da Silva L, Corton M, Perez-Carro R, et al. A comprehensive analysis of choroideremia: from genetic characterization to clinical practice. PLoS One. 2016;11(4):e0151943. doi:10.1371/journal.pone.0151943.
   PubMed Web of Science ®Google Scholar
• Spraul CW, Grossniklaus HE. Characteristics of drusen and bruch’s membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol. 1997;115(2):267–73. doi:10.1001/archopht.1997.01100150269022.
   PubMedGoogle Scholar
• Rishi P, Bharat RPK, Rishi E, Bhende M, Biswas J, Ahmed A, Sudharshan S, Sankara Nethralaya Vitreoretinal Study Group. Choroidal neovascularization in 111 eyes of children and adolescents. Int Ophthalmol. 2022;42(1):157–66. doi:10.1007/s10792-021-02018-2.
   PubMed Web of Science ®Google Scholar
• Henry CR, Sisk RA, Tzu JH, Albini TA, Davis JL, Murray TG, Berrocal AM. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases. J Aapos. 2015;19(6):541–8. doi:10.1016/j.jaapos.2015.09.006.
   PubMed Web of Science ®Google Scholar
• Sisk RA, Berrocal AM, Albini TA, Murray TG. Bevacizumab for the treatment of pediatric retinal and choroidal diseases. Ophthalmic Surg Lasers Imaging. 2010;41(6):582–92. doi:10.3928/15428877-20100830-03.
   Google Scholar
• Rich R, Vanderveldt S, Berrocal AM, Mavrofrides EC, Murray TG, Gregori N. Treatment of choroidal neovascularization associated with best’s disease in children. J Pediatr Ophthalmol Strabismus. 2009;46(5):306–11. doi:10.3928/01913913-20090903-10.
   PubMed Web of Science ®Google Scholar
• Chen RC, Traboulsi EI, Rachitskaya A. Chronic choroidal neovascular membrane in choroideremia treated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging Retina. 2019;50(6):e188–e92. doi:10.3928/23258160-20190605-15.
   PubMed Web of Science ®Google Scholar
• Palejwala NV, Lauer AK, Weleber RG. Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab. Clin Ophthalmol. 2014;8:1675–9. doi:10.2147/OPTH.S68243.
   PubMedGoogle Scholar
• Robinson D, Tiedeman J. Choroideremia associated with a subretinal neovascular membrane. Case Report Retina. 1987 Summer;7(2):70–4. doi:10.1097/00006982-198700720-00002.
   Google Scholar
• Endo K, Yuzawa M, Ohba N. Choroideremia associated with subretinal neovascular membrane. Acta Ophthalmol Scand. 2000;78(4):483–6. doi:10.1034/j.1600-0420.2000.078004483.x.
   PubMedGoogle Scholar
• Sawa M, Tamaki Y, Klancnik JM Jr., Yannuzzi LA. Intraretinal foveal neovascularization in choroideremia. Retina. 2006;26(5):585–8. doi:10.1097/00006982-200605000-00016.
   PubMed Web of Science ®Google Scholar
• Campos-Pavon J, Torres-Pena JL. Choroidal neovascularization secondary to choroideremia. Arch Soc Esp Oftalmol. 2015;90(6):289–91. doi:10.1016/j.oftal.2014.03.012.
   PubMedGoogle Scholar
• Miere A, Oubraham H, Amoroso F, Butori P, Astroz P, Semoun O, Bruyere E, Pedinielli A, Addou-Regnard M, Jung C, et al. Optical coherence tomography angiography to distinguish changes of choroidal neovascularization after anti-VEGF therapy: monthly loading dose versus pro re nata regimen. J Ophthalmol. 2018;2018:1–7.
   Web of Science ®Google Scholar